What is the Impact Factor of Molecular Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Molecular Cancer is 42.2, ranking in quartile Q1 of Web of Science (SCIE).

Is Molecular Cancer indexed in Web of Science or Scopus?

Yes, Molecular Cancer is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 9.908 (Q1) and an H-index of 242.

Who publishes Molecular Cancer and what is the Article Processing Charge (APC)?

Molecular Cancer is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $4,950 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Molecular Cancer?

The official ISO-4 abbreviation of Molecular Cancer is "MOL CANCER". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #89Top JournalGold OA

Molecular Cancer

Abbreviation (ISO):MOL CANCER

•

Identifier (ISSN):1476-4598(Print)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

42.2↑ +8.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Molecular Cancer

WoS Q1

Annual Impact Factor Metric

Current (2026):42.2

Scopus SJR & RankScopus Q1

9.908

#89

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

242

242 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate2.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

129articles/year

100% Gold OA•65.27% Original Research

Aims & Scope

Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.

Topics Covered (Recognized by AI)

Biology99.4%Genetics98.5%Medicine97%Chemistry94.7%Biochemistry94.3%Internal medicine89.9%Cancer research88.6%Gene79.2%Cancer76.4%Cell biology49.8%Apoptosis38.4%Cell culture32%Immunology32%Pathology29.9%Cell26.2%Signal transduction25.4%Molecular biology22.3%Gene expression21.9%

Primary Research Areas

Medicine Biochemistry & Molecular Biology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Rank4/328

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank8/333

IndexSCIE

JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Rank4/328

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank11/333

IndexSCIE

Category	Index	Rank	Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY	JCRSCIE	4/328	Q1
ONCOLOGY	JCRSCIE	8/333	Q1
BIOCHEMISTRY & MOLECULAR BIOLOGY	JCISCIE	4/328	Q1
ONCOLOGY	JCISCIE	11/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF42.2

Articles / Year267

Total Citations484

2025

IF33.9

Articles / Year332

Total Citations9,618

2024

IF27.7

Articles / Year285

Total Citations15,545

2023

IF37.3

Articles / Year209

Total Citations23,602

2022

IF41.444

Articles / Year229

Total Citations29,399

Year	Impact Factor	Articles / Year	Total Citations
2026	42.2	267	484
2025	33.9	332	9,618
2024	27.7	285	15,545
2023	37.3	209	23,602
2022	41.444	229	29,399
2021	27.401	172	24,533
2020	15.302	174	43,744
2019	10.679	188	58,576
2018	7.776	178	34,720
2017	—	180	31,053
2016	—	83	9,362
2015	—	214	17,788

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #89Scopus Q1SCImago Profile

Scopus Coverage:2002-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

9.908

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

32.77

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,950 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations22,706

3-Year Documents666

Citable Documents558

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1

Molecular MedicineQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区BIOCHEMISTRY & MOLECULAR BIOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Cancer (abbr: MOL CANCER, ISSN: 1476-4598) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in England since 2002. The periodical holds a Journal Impact Factor (JIF) of 42.2, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 9.908 (Q1), an H-index of 242.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 129 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,950 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.